Curing Type 1 Diabetes Without Lifelong Immunosuppression

Think of blood sugar as the water level in a tank, kept steady by an automatic valve. Intype 1 diabetes the body’s own immune system destroys the valve, so the level swingsdangerously and the person must dose insulin by hand for life. The real fix is to install anew valve — new insulin-making cells — and this now works well enough that most peoplein a recent trial stopped needing injected insulin. The catch is that the immune systemattacks any new cells, so patients must take powerful drugs that switch off immunedefenses, which brings its own dangers. The frontier, and the subject of this paper, is anew valve the immune system simply does not see: insulin-making cells engineered tohide their identity tags. In 2025 this was shown to work in a person for the first time, withno immune-suppressing drugs at all — though the dose was small on purpose, as a firsttest. This paper explains why that is the right target, gives a simple mathematical modelanyone can run, and is honest about what still has to be proven.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-08-20
DOI
https://doi.org/10.5281/zenodo.22035647
Primary Topic
Diabetes and associated disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Curing Type 1 Diabetes Without Lifelong Immunosuppression

Marc Anthony Ramirez
Zenodo (CERN European Organization for Nuclear Research)
Diabetes and associated disorders
preprint

Curing Type 1 Diabetes Without Lifelong Immunosuppression

Marc Anthony Ramirez
preprint en

Abstract

Think of blood sugar as the water level in a tank, kept steady by an automatic valve. Intype 1 diabetes the body’s own immune system destroys the valve, so the level swingsdangerously and the person must dose insulin by hand for life. The real fix is to install anew valve — new insulin-making cells — and this now works well enough that most peoplein a recent trial stopped needing injected insulin. The catch is that the immune systemattacks any new cells, so patients must take powerful drugs that switch off immunedefenses, which brings its own dangers. The frontier, and the subject of this paper, is anew valve the immune system simply does not see: insulin-making cells engineered tohide their identity tags. In 2025 this was shown to work in a person for the first time, withno immune-suppressing drugs at all — though the dose was small on purpose, as a firsttest. This paper explains why that is the right target, gives a simple mathematical modelanyone can run, and is honest about what still has to be proven.

Zenodo (CERN European Organization for Nuclear Research)
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.